Cerity Partners’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.9M Sell
343,589
-5,548
-2% -$378K 0.03% 397
2026
Q1
$22.6M Sell
349,137
-11,068
-3% -$780K 0.03% 409
2025
Q4
$24.2M Buy
360,205
+11,908
+3% +$801K 0.04% 376
2025
Q3
$25.5M Buy
348,297
+22,403
+7% +$1.49M 0.04% 336
2025
Q2
$17M Buy
325,894
+35,001
+12% +$1.99M 0.03% 396
2025
Q1
$18.6M Sell
290,893
-43,959
-13% -$2.55M 0.04% 354
2024
Q4
$16.4M Buy
334,852
+35,064
+12% +$1.8M 0.04% 363
2024
Q3
$17.2M Buy
299,788
+8,732
+3% +$501K 0.04% 352
2024
Q2
$15.2M Sell
291,056
-4,485
-2% -$197K 0.04% 323
2024
Q1
$12M Buy
295,541
+26,023
+10% +$976K 0.03% 402
2023
Q4
$9.96M Buy
269,518
+16,286
+6% +$613K 0.03% 379
2023
Q3
$9.67M Sell
253,232
-4,889
-2% -$200K 0.05% 301
2023
Q2
$9.31M Buy
258,121
+2,533
+1% +$86.4K 0.04% 356
2023
Q1
$9.76M Sell
255,588
-3,692
-1% -$173K 0.02% 360
2022
Q4
$14.8M Buy
259,280
+252,580
+3,770% +$12.9M 0.09% 204
2022
Q3
$265K Buy
6,700
+747
+13% +$33K ﹤0.01% 951
2022
Q2
$262K Buy
+5,953
New +$257K ﹤0.01% 962

Other funds holding HALO

Cerity Partners's HALO Position: Q2 2026 in Review

Cerity Partners reduced its Halozyme (HALO) stake by 1.6% in Q2 2026, selling an estimated $378K and leaving 343,589 shares worth $26.9M. The position accounts for 0.03% of the portfolio, ranked #397.

Cerity Partners first reported a position in HALO in Q2 2022 and has held it in 17 quarters since. 629 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Cerity Partners held 343,589 shares of Halozyme worth $26.9M as of Q2 2026.
  • Cerity Partners sold 5,548 Halozyme shares in Q2 2026, an estimated $378K.
  • Halozyme made up 0.03% of Cerity Partners's portfolio in Q2 2026, its #397 holding.
  • Cerity Partners first reported a position in Halozyme in Q2 2022 and has held it in 17 quarters since.
  • 629 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.